Comparing KM04 to Gonal-f in healthy women
This study tests a new medicine called KM04 against a standard fertility medicine, Gonal-f, in healthy women. It checks how the body processes KM04 and if it is safe. You would not directly benefit, but you would help research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 40 years old.
- You are generally healthy, with a weight of at least 45 kg (about 99 lbs) and a healthy body mass index (BMI) between 18 and 30.
- You have both ovaries and a regular menstrual cycle (24–35 days) before starting birth control pills.
- You are willing to take combined oral contraceptives (birth control pills) for the whole study period and for at least 2 menstrual cycles before the study starts.
- You have not used tobacco or nicotine products in the last 3 months.
- You must not be pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two doses of follicle-stimulating hormone (FSH) to find out which dose helps women with normal ovarian reserve have better IVF outcomes. It aims to improve the chances of a successful pregnancy.
This study compares a new injected hormone (SJ04) with a standard one (Ovidrel) to see if they work similarly. It's for healthy women with regular cycles who might need help with fertility treatments.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
This study tests a fertility medication (human menopausal gonadotropin) to see how well it helps women have a live birth after IVF with frozen embryos. It compares the medication's effectiveness for women with infertility who are planning to freeze all embryos and transfer them later.
This study tests how safe and tolerable a new drug, KSHN001034, is in healthy women who have gone through menopause. It involves multiple doses to see how your body processes the medicine.
This trial compares two different medications (Corifollitropin alpha and daily rFSH) to stimulate egg production in healthy egg donors. It aims to see if a single injection of Corifollitropin alpha works as well as the usual daily shots, making the process simpler and more comfortable.
Hear when a new Healthy Female Adult Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.